Search Results - "Konik, Ewa A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    The role of pulmonary vascular contractile protein expression in pulmonary arterial hypertension by Konik, Ewa A, Han, Young Soo, Brozovich, Frank V

    “…Abstract Pulmonary arterial hypertension (PAH) is associated with refractory vasoconstriction and impaired NO-mediated vasodilatation of the pulmonary…”
    Get full text
    Journal Article
  2. 2

    Effect of atrial fibrillation duration on plasma von Willebrand factor level by Wysokinski, Waldemar E., Cohoon, Kevin P., Konik, Ewa A., Melduni, Rowlens M., Ammash, Naser M., Asirvatham, Samuel J., McBane, Robert D.

    Published in European journal of haematology (01-12-2017)
    “…Aims von Willebrand factor (VWF) is an independent risk factor for adverse events in patients with non‐valvular atrial fibrillation (NVAF). However, it is…”
    Get full text
    Journal Article
  3. 3

    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction by Fayyaz, Ahmed U, Edwards, William D, Maleszewski, Joseph J, Konik, Ewa A, DuBrock, Hilary M, Borlaug, Barry A, Frantz, Robert P, Jenkins, Sarah M, Redfield, Margaret M

    Published in Circulation (New York, N.Y.) (24-04-2018)
    “…BACKGROUND:We hypothesized that pulmonary venous hypertension in heart failure (HF) leads to predominate remodeling of pulmonary veins and that the severity of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Left Atrial Blood Stasis and Von Willebrand Factor–ADAMTS13 Homeostasis in Atrial Fibrillation by Ammash, Naser, Konik, Ewa A, McBane, Robert D, Chen, Dong, Tange, Julie I, Grill, Diane E, Herges, Regina M, McLeod, Thomas G, Friedman, Paul A, Wysokinski, Waldemar E

    “…OBJECTIVE—Left atrial blood stasis is associated with increased risk for left atrial appendage thrombus (LAAT) and stroke in atrial fibrillation (AF). Von…”
    Get full text
    Journal Article
  6. 6

    Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure by Odiete, Oghenerukevwe, Konik, Ewa A, Sawyer, Douglas B, Hill, Michael F

    Published in Cardiovascular diabetology (27-03-2013)
    “…Diabetes mellitus (DM) patients surviving myocardial infarction (MI) exhibit a substantially higher incidence of subsequent heart failure (HF). Neuregulin…”
    Get full text
    Journal Article
  7. 7

    Severe pulmonic valve regurgitation due to histoplasma endocarditis by Konik, Ewa A, Bremer, Merri, Lin, Peter T, Pislaru, Sorin V

    Published in Echo research and practice (01-03-2015)
    “…SummaryA 67-year-old man with myelodysplastic syndrome, disseminated histoplasmosis, and mitral valve replacement presented with dyspnea and peripheral edema…”
    Get full text
    Journal Article
  8. 8

    Herbs and Dietary Supplements in the European Union: A Review of the Regulations with Special Focus on Germany and Poland by Konik, Ewa A., Jungling, Roman C., Bauer, Brent A.

    Published in Journal of dietary supplements (01-03-2011)
    “…ABSTRACT In the European Union, the manufacturing of and the trade in herbs and dietary supplements are regulated by pharmaceutical and food laws. While…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1[beta]/ErbB in response to myocardial infarction resulting in worsening heart failure by Odiete, Oghenerukevwe, Konik, Ewa A, Sawyer, Douglas B, Hill, Michael F

    Published in Cardiovascular diabetology (27-03-2013)
    “…Doc number: 52 Abstract Background: Diabetes mellitus (DM) patients surviving myocardial infarction (MI) exhibit a substantially higher incidence of subsequent…”
    Get full text
    Journal Article
  12. 12

    Severe pulmonic valve regurgitation due to histoplasma endocarditis by Konik, Ewa A, Bremer, Merri, Lin, Peter T, Pislaru, Sorin V

    Published in Echo research and practice (01-03-2015)
    “…UNLABELLEDA 67-year-old man with myelodysplastic syndrome, disseminated histoplasmosis, and mitral valve replacement presented with dyspnea and peripheral…”
    Get full text
    Report